Shots:

• Pear collaborates with Empatica- etectRx and KeyWise to bolster its PDT platform with digital biomarkers- machine learning algorithms- sensor-based technologies- and digital therapeutics
• The new technologies complement its voice-based biomarkers previously licensed from Winterlight. The licensed technologies will facilitate the building of products for patients’ physiologic sensing
• Pear’s physiologic sensing portfolio allows personalizing products in real-time and pharmaceutical dosing- thus providing an opportunity for enhanced patient outcomes across a wide range of disease states

  Ref: Pear Therapeutics | Image: PMLive